|
BCL7A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.457620E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.476600E-01 |
| Normal-vs-Stage2 |
8.578200E-01 |
| Normal-vs-Stage3 |
3.520400E-01 |
| Normal-vs-Stage4 |
4.759200E-01 |
| Stage1-vs-Stage2 |
5.729800E-01 |
| Stage1-vs-Stage3 |
5.440400E-01 |
| Stage1-vs-Stage4 |
2.824000E-01 |
| Stage2-vs-Stage3 |
3.870000E-01 |
| Stage2-vs-Stage4 |
5.261600E-01 |
| Stage3-vs-Stage4 |
2.560400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.488200E-01 |
| Normal-vs-AfricanAmerican |
1.843970E-01 |
| Normal-vs-Asian |
3.843900E-02 |
| Caucasian-vs-AfricanAmerican |
8.737800E-01 |
| Caucasian-vs-Asian |
1.452810E-01 |
| AfricanAmerican-vs-Asian |
7.530300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.948550E-01 |
| Normal-vs-Female |
2.024600E-01 |
| Male-vs-Female |
8.262200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.978000E-01 |
| Normal-vs-Extreme_Weight |
7.190600E-01 |
| Normal-vs-Obese |
8.904100E-02 |
| Normal-vs-Extreme_Obese |
6.783800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.796800E-01 |
| Normal_Weight-vs-Obese |
1.588820E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.868200E-01 |
| Extreme_Weight-vs-Obese |
2.040800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.392200E-01 |
| Obese-vs-Extreme_Obese |
5.594400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.876790E-01 |
| Normal-vs-Age(41-60Yrs) |
2.450300E-02 |
| Normal-vs-Age(61-80Yrs) |
9.037200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.492000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.147800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.447600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.312800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.521900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.721800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.922000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.758500E-03 |
| Normal-VS-Type2 PRCC |
1.634230E-01 |
| Normal-VS-KIRP CIMP |
8.464600E-03 |
| Normal-VS-Unclassified PRCC |
9.242400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.447570E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.570100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
7.929000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.713000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.765630E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.376800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.348000E-01 |
| Normal-vs-N1 |
6.205200E-01 |
| Normal-vs-N2 |
5.317000E-01 |
| N0-vs-N1 |
4.723000E-01 |
| N0-vs-N2 |
4.689400E-01 |
| N1-vs-N2 |
2.309400E-01 |
|
|
